a16z Video: Shifting Risk Mindsets, from Tech to Bio

Jorge Conde, Vijay Pande, and Jeffrey Low

watch time: 26 minutes

What challenges do first-time founders or tech founders encounter when building companies in the bio space, and how does it differ from traditional tech companies? In this hallway-style conversation, a16z bio team partners — including general partners Jorge Conde and Vijay Pande, with Jeff Low — discuss the mindset shifts involved with building bio (and especially therapeutics) companies.

They cover everything from different paths to market and different partnerships (including pharma), to different timelines and milestones for validating the product and business itself. And finally, how do we get to common language that bridges the worlds of tech and bio?

Want more a16z Bio + Health?

Sign up for our bio + health newsletter to get the latest take from us on the future of biology, technology, and care delivery.

Thanks for signing up for the a16z Bio + Health newsletter.

Check your inbox for a welcome note.

MANAGE MY SUBSCRIPTIONS By clicking the Subscribe button, you agree to the Privacy Policy.